Literature DB >> 10727103

Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion.

M Ocampo1, M Urquiza, F Guzmán, L E Rodriguez, J Suarez, H Curtidor, J Rosas, M Diaz, M E Patarroyo.   

Abstract

Plasmodium falciparum merozoite membrane surface antigen 2 (MSA2) has been associated with the development of protective immunity against malaria. MSA2 antibodies were able to inhibit in vitro merozoite invasion. In our search for experimental evidence concerning the participation of MSA2 in merozoite invasion, 40 peptides were synthesized according to sequences reported for the CAMP and FC27 prototype Plasmodium strains. These peptides were purified, 125I-radiolabeled and tested for their ability to bind to erythrocytes. Two MSA2 synthetic peptides with high specific binding to human erythrocytes were found. The peptide coded 4044 (KNESKYSNTFINNAYNMSIR), located in the MSA2 N-terminal conserved region, has an affinity coefficient of 72 nM and showed a positive cooperativity for the receptor-ligand interaction. The other peptide, coded 4053 (NPNHKNAETNPKGKGEVQKP) and located in the central variable region of MSA2, has an affinity coefficient of 49nM and also showed a positive cooperativity for the receptor-ligand interaction. The binding capacity of these peptides is affected by erythrocytes treated with neuraminidase and trypsin, but it is not affected by chymotrypsin. Both of these sequences inhibit in vitro erythrocyte parasite invasion by up to 95% suggesting that they have an important role in the parasite's invasion process. Furthermore, as published previously [A. Saul et al. (1992) J. Immunol., 148, 208-211], a protective B epitope is included in the 4044 peptide sequence.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10727103     DOI: 10.1034/j.1399-3011.2000.00174.x

Source DB:  PubMed          Journal:  J Pept Res        ISSN: 1397-002X


  10 in total

1.  Identifying Plasmodium falciparum cytoadherence-linked asexual protein 3 (CLAG 3) sequences that specifically bind to C32 cells and erythrocytes.

Authors:  Marisol Ocampo; Luis E Rodríguez; Hernando Curtidor; Alvaro Puentes; Ricardo Vera; John J Valbuena; Ramses López; Javier E García; Luis E Ramírez; Elizabeth Torres; Jimena Cortes; Diana Tovar; Yolanda López; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

2.  Identifying putative Mycobacterium tuberculosis Rv2004c protein sequences that bind specifically to U937 macrophages and A549 epithelial cells.

Authors:  Martha Forero; Alvaro Puentes; Jimena Cortés; Fabio Castillo; Ricardo Vera; Luis E Rodríguez; John Valbuena; Marisol Ocampo; Hernando Curtidor; Jaiver Rosas; Javier García; Gloria Barrera; Rosalba Alfonso; Manuel A Patarroyo; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-09-30       Impact factor: 6.725

3.  Identifying Plasmodium falciparum merozoite surface antigen 3 (MSP3) protein peptides that bind specifically to erythrocytes and inhibit merozoite invasion.

Authors:  Luis E Rodríguez; Hernando Curtidor; Marisol Ocampo; Javier Garcia; Alvaro Puentes; John Valbuena; Ricardo Vera; Ramses López; Manuel E Patarroyo
Journal:  Protein Sci       Date:  2005-07       Impact factor: 6.725

4.  3D analysis of the TCR/pMHCII complex formation in monkeys vaccinated with the first peptide inducing sterilizing immunity against human malaria.

Authors:  Manuel A Patarroyo; Adriana Bermúdez; Carolina López; Gloria Yepes; Manuel E Patarroyo
Journal:  PLoS One       Date:  2010-03-19       Impact factor: 3.240

5.  Redefining an epitope of a malaria vaccine candidate, with antibodies against the N-terminal MSA-2 antigen of Plasmodium harboring non-natural peptide bonds.

Authors:  José Manuel Lozano; Yuly Andrea Guerrero; Martha Patricia Alba; Liliana Patricia Lesmes; José Oswaldo Escobar; Manuel Elkin Patarroyo
Journal:  Amino Acids       Date:  2013-07-09       Impact factor: 3.520

6.  Plasmodium vivax Pv12 B-cell epitopes and HLA-DRβ1*-dependent T-cell epitopes in vitro antigenicity.

Authors:  Yoelis Yepes-Pérez; Carolina López; Carlos Fernando Suárez; Manuel Alfonso Patarroyo
Journal:  PLoS One       Date:  2018-09-10       Impact factor: 3.240

Review 7.  Strategies for developing multi-epitope, subunit-based, chemically synthesized anti-malarial vaccines.

Authors:  M E Patarroyo; G Cifuentes; A Bermúdez; M A Patarroyo
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

8.  Sequence variation in Plasmodium falciparum merozoite surface protein-2 is associated with virulence causing severe and cerebral malaria.

Authors:  Suwanna Chaorattanakawee; Pornlada Nuchnoi; Hathairad Hananantachai; Uranan Tumkosit; David Saunders; Izumi Naka; Jun Ohashi; Jintana Patarapotikul
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

9.  The in Vitro Antigenicity of Plasmodium vivax Rhoptry Neck Protein 2 (PvRON2) B- and T-Epitopes Selected by HLA-DRB1 Binding Profile.

Authors:  Carolina López; Yoelis Yepes-Pérez; Diana Díaz-Arévalo; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  Front Cell Infect Microbiol       Date:  2018-05-15       Impact factor: 5.293

10.  Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model.

Authors:  Jennifer Lambraño; Hernando Curtidor; Catalina Avendaño; Diana Díaz-Arévalo; Leonardo Roa; Magnolia Vanegas; Manuel E Patarroyo; Manuel A Patarroyo
Journal:  J Immunol Res       Date:  2019-12-30       Impact factor: 4.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.